IBDEI0C7 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5794,0)
 ;;=628.9^^49^520^5
 ;;^UTILITY(U,$J,358.3,5794,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5794,1,4,0)
 ;;=4^FEMALE INFERTILITY NOS
 ;;^UTILITY(U,$J,358.3,5794,1,5,0)
 ;;=5^628.9
 ;;^UTILITY(U,$J,358.3,5794,2)
 ;;=^62820
 ;;^UTILITY(U,$J,358.3,5795,0)
 ;;=611.6^^49^520^6
 ;;^UTILITY(U,$J,358.3,5795,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5795,1,4,0)
 ;;=4^GALACTORRHEA-NONOBSTET
 ;;^UTILITY(U,$J,358.3,5795,1,5,0)
 ;;=5^611.6
 ;;^UTILITY(U,$J,358.3,5795,2)
 ;;=^270460
 ;;^UTILITY(U,$J,358.3,5796,0)
 ;;=256.1^^49^520^11
 ;;^UTILITY(U,$J,358.3,5796,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5796,1,4,0)
 ;;=4^OVARIAN HYPERFUNC NEC
 ;;^UTILITY(U,$J,358.3,5796,1,5,0)
 ;;=5^256.1
 ;;^UTILITY(U,$J,358.3,5796,2)
 ;;=^267878
 ;;^UTILITY(U,$J,358.3,5797,0)
 ;;=704.1^^49^520^7
 ;;^UTILITY(U,$J,358.3,5797,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5797,1,4,0)
 ;;=4^HIRSUTISM
 ;;^UTILITY(U,$J,358.3,5797,1,5,0)
 ;;=5^704.1
 ;;^UTILITY(U,$J,358.3,5797,2)
 ;;=^57407
 ;;^UTILITY(U,$J,358.3,5798,0)
 ;;=627.2^^49^520^9
 ;;^UTILITY(U,$J,358.3,5798,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5798,1,4,0)
 ;;=4^MENOPAUSE
 ;;^UTILITY(U,$J,358.3,5798,1,5,0)
 ;;=5^627.2
 ;;^UTILITY(U,$J,358.3,5798,2)
 ;;=^328735
 ;;^UTILITY(U,$J,358.3,5799,0)
 ;;=256.31^^49^520^8
 ;;^UTILITY(U,$J,358.3,5799,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5799,1,4,0)
 ;;=4^MANOPAUSE,PREMATURE
 ;;^UTILITY(U,$J,358.3,5799,1,5,0)
 ;;=5^256.31
 ;;^UTILITY(U,$J,358.3,5799,2)
 ;;=^75883
 ;;^UTILITY(U,$J,358.3,5800,0)
 ;;=256.39^^49^520^10
 ;;^UTILITY(U,$J,358.3,5800,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5800,1,4,0)
 ;;=4^OTHER OVARIAN FAILURE
 ;;^UTILITY(U,$J,358.3,5800,1,5,0)
 ;;=5^256.39
 ;;^UTILITY(U,$J,358.3,5800,2)
 ;;=^330824
 ;;^UTILITY(U,$J,358.3,5801,0)
 ;;=256.4^^49^520^13
 ;;^UTILITY(U,$J,358.3,5801,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5801,1,4,0)
 ;;=4^POLYCYSTIC OVARIES
 ;;^UTILITY(U,$J,358.3,5801,1,5,0)
 ;;=5^256.4
 ;;^UTILITY(U,$J,358.3,5801,2)
 ;;=^96086
 ;;^UTILITY(U,$J,358.3,5802,0)
 ;;=616.10^^49^520^17
 ;;^UTILITY(U,$J,358.3,5802,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5802,1,4,0)
 ;;=4^VAGINITIS NOS
 ;;^UTILITY(U,$J,358.3,5802,1,5,0)
 ;;=5^616.10
 ;;^UTILITY(U,$J,358.3,5802,2)
 ;;=^125233
 ;;^UTILITY(U,$J,358.3,5803,0)
 ;;=627.3^^49^520^18
 ;;^UTILITY(U,$J,358.3,5803,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5803,1,4,0)
 ;;=4^VAGINITIS,ATROPHIC
 ;;^UTILITY(U,$J,358.3,5803,1,5,0)
 ;;=5^627.3
 ;;^UTILITY(U,$J,358.3,5803,2)
 ;;=^270577
 ;;^UTILITY(U,$J,358.3,5804,0)
 ;;=112.1^^49^520^19
 ;;^UTILITY(U,$J,358.3,5804,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5804,1,4,0)
 ;;=4^VAGINITIS,CANDIDAL
 ;;^UTILITY(U,$J,358.3,5804,1,5,0)
 ;;=5^112.1
 ;;^UTILITY(U,$J,358.3,5804,2)
 ;;=^18615
 ;;^UTILITY(U,$J,358.3,5805,0)
 ;;=131.01^^49^520^20
 ;;^UTILITY(U,$J,358.3,5805,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5805,1,4,0)
 ;;=4^VAGINITIS,TRICHOMONAL
 ;;^UTILITY(U,$J,358.3,5805,1,5,0)
 ;;=5^131.01
 ;;^UTILITY(U,$J,358.3,5805,2)
 ;;=^121763
 ;;^UTILITY(U,$J,358.3,5806,0)
 ;;=193.^^49^521^15
 ;;^UTILITY(U,$J,358.3,5806,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5806,1,4,0)
 ;;=4^THYROID CANCER
 ;;^UTILITY(U,$J,358.3,5806,1,5,0)
 ;;=5^193.
 ;;^UTILITY(U,$J,358.3,5806,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,5807,0)
 ;;=240.9^^49^521^3
 ;;^UTILITY(U,$J,358.3,5807,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5807,1,4,0)
 ;;=4^GOITER NOS
 ;;^UTILITY(U,$J,358.3,5807,1,5,0)
 ;;=5^240.9
 ;;^UTILITY(U,$J,358.3,5807,2)
 ;;=^52400
 ;;^UTILITY(U,$J,358.3,5808,0)
 ;;=241.1^^49^521^10
 ;;^UTILITY(U,$J,358.3,5808,1,0)
 ;;=^358.31IA^5^2
